Federal Register / Vol. 74, No. 156 / Friday, August 14, 2009 / Notices 41125 

Conservation, and Education Division, 

Office of Protected Resources, National 

Marine Fisheries Service, 1315 EastWest Highway, Silver Spring, MD 

20910–3235 or by telephoning the 

contact listed here (see FOR FURTHER

INFORMATION CONTACT), or online at: 

http://www.nmfs.noaa.gov/pr/permits/ 

incidental.htm. Documents cited in this 

notice may be viewed, by appointment, 

during regular business hours, at the 

aforementioned address. 

FOR FURTHER INFORMATION CONTACT: 

Howard Goldstein or Ken Hollingshead, 

Office of Protected Resources, NMFS, 

301–713–2289. 

SUPPLEMENTARY INFORMATION: Section 

101(a)(5)(A) of the MMPA (16 U.S.C. 

1361 et seq.) directs the NMFS to allow, 

upon request, the incidental, but not 

intentional, taking of small numbers of 

marine mammals by United States 

citizens who engage in a specified 

activity (other than commercial fishing) 

within a specified geographical region, 

if certain findings are made by NMFS 

and regulations are issued. Under the 

MMPA, the term ‘‘taking’’ means to 

harass, hunt, capture, or kill or to 

attempt to harass, hunt capture, or kill 

marine mammals. 

Authorization for incidental taking, in 

the form of an annual LOA, may be 

granted by NMFS for periods up to five 

years if NMFS finds, after notification 

and opportunity for public comment, 

that the taking will have a negligible 

impact on the species or stock(s) of 

marine mammals, and will not have an 

unmitigable adverse impact on the 

availability of the species or stock(s) for 

subsistence uses (where relevant). In 

addition, NMFS must prescribe 

regulations that include permissible 

methods of taking and other means 

effecting the least practicable adverse 

impact on the species and its habitat 

(i.e., mitigation), and on the availability 

of the species for subsistence uses, 

paying particular attention to rookeries, 

mating rounds, and areas of similar 

significance. The regulations also must 

include requirements pertaining to the 

monitoring and reporting of such taking. 

Regulations governing the taking 

incidental to EROS were published on 

June 19, 2008 (73 FR 34889), and remain 

in effect through July 19, 2013. For 

detailed information on this action, 

please refer to that Federal Register 

notice. The species that applicants may 

take in small numbers during EROS 

activities are bottlenose dolphins 

(Tursiops truncatus), Atlantic spotted 

dolphins (Stenella frontalis), 

pantropical spotted dolphins (Stenella 

attenuata), Clymene dolphins (Stenella 

clymene), striped dolphins (Stenella 

coeruleoalba), spinner dolphins 

(Stenella longirostris), rough-toothed 

dolphins (Steno bredanensis), Risso’s 

dolphins (Grampus griseus), melonheaded whales (Peponocephala electra), 

short-finned pilot whales (Globicephala 

macrorhynchus), and sperm whales 

(Physeter macrocephalus). 

Pursuant to these regulations, NMFS 

has issued an LOA to EOG Resources, 

Inc. Issuance of the LOA is based on a 

finding made in the preamble to the 

final rule that the total taking by these 

activities (with monitoring, mitigation, 

and reporting measures) will result in 

no more than a negligible impact on the 

affected species or stock(s) of marine 

mammals and will not have an 

unmitigable adverse impact on 

subsistence uses. NMFS also finds that 

the applicant will meet the 

requirements contained in the 

implementing regulations and LOA, 

including monitoring, mitigation, and 

reporting requirements. 

Dated: August 10, 2009. 

James H. Lecky, 

Director, Office of Protected Resources, 

National Marine Fisheries Service. 

[FR Doc. E9–19546 Filed 8–13–09; 8:45 am] 

BILLING CODE 3510–22–S 

DEPARTMENT OF COMMERCE 

International Trade Administration 

Medical Trade Mission to India 

AGENCY: International Trade 

Administration, Department of 

Commerce. 

ACTION: Notice. 

Mission Description 

The United States Department of 

Commerce, International Trade 

Administration, U.S. and Foreign 

Commercial Service is organizing a 

Medical Trade Mission to New Delhi, 

Chennai and Mumbai, India, March 8– 

13, 2010. The Medical Trade Mission to 

India will include representatives of 

U.S. medical/healthcare industry 

manufacturers (equipment and devices 

including laboratory, emergency, 

diagnostic, physiotherapy, and 

orthopedic equipment, and healthcare 

information technology) and service 

providers. The mission will introduce 

U.S. suppliers to prospective end-users 

and partners whose needs and 

capabilities are targeted to each U.S. 

participant’s business objectives. The 

delegates will meet with Indian 

government officials to obtain first-hand 

information about regulations, policies 

and procedures and will visit healthcare 

facilities. The Commercial Service in 

India (CS India) will organize 

appointments and briefings in New 

Delhi, Chennai and Mumbai, India’s 

major healthcare industry hubs. U.S. 

participants will have the opportunity 

to interact with U.S. Embassy and 

Consulate officials and CS India 

healthcare specialists to discuss 

industry developments, opportunities, 

and marketing strategies. 

Medical Fair India, one of the largest 

medical tradeshows in India, coincides 

in time and location with the last stop 

of the Trade Mission. Trade Mission 

participants, therefore, can exhibit at the 

tradeshow, in the U.S. Pavilion, as part 

of their program. Companies wishing to 

exhibit in the U.S. pavilion at the 

Medical Fair can register through the CS 

India office to receive a discount. 

Commercial Setting 

The Indian healthcare industry is 

experiencing a rapid transformation and 

is emerging as a promising market for 

U.S. suppliers of high-end products. 

The Indian healthcare market, currently 

at $35 billion annually, is expected to 

reach more than $75 billion annually by 

2012. The growth in affluence of more 

than 300 million middle-income 

consumers is creating demand for 

higher standards of healthcare. The 

changing demographic profile and the 

rise of lifestyle-related diseases have 

altered the health seeking behavior of 

the consumer. While private insurance 

covers only 10% of the population, 

coverage is growing at 40% per year. 

The medical infrastructure in India is 

insufficient for the population, with 

demand for hospitals and beds far 

exceeding supply. The problem is acute 

in rural India, which accounts for over 

half of India’s population, while about 

80 percent of available hospital beds are 

located in the urban centers. Both 

government and private operators have 

major expansion plans to meet demand 

and increase quality. Healthcare in India 

is provided through primary care 

facilities and secondary and tertiary care 

hospitals. While the public sector 

provides primary and secondary care, 

tertiary care hospitals are owned and 

managed by both government and 

private sector. Over the next 5–6 years, 

150–200 tertiary hospital projects are 

expected to be constructed, including 

hospitals of varying capacities. Most 

Indian healthcare facilities use imported 

medical equipment for diagnosis, 

treatment and surgery with over 35% of 

the imports coming from the U.S. New 

specialty and super-specialty hospitals 

depend on the import of high-end 

medical equipment for over 65 percent 

mstockstill on DSKH9S0YB1PROD with NOTICES

41126 Federal Register / Vol. 74, No. 156 / Friday, August 14, 2009 / Notices 

of their needs, and this sector is growing 

at a rate of 15 percent annually. 

Medical tourism is one of the major 

external drivers of growth in India’s 

healthcare sector. India treated 450,000 

foreign patients in 2007 and the 

expected increase in this sector is 

contributing to improved quality 

controls. India’s National Accreditation 

Board for Hospitals (NABH) operates 

accreditation programs for healthcare 

organizations. Some private hospitals 

are also applying for certification from 

international accreditation organizations 

such as the Joint Commission 

International (JCI). Accreditation by 

NABH and JCI has ensured better 

standards of healthcare in hospitals. 

Mission Goals 

The goal of the Medical Trade 

Mission to India is to (1) familiarize the 

U.S. companies with the current 

healthcare situation as well as the 

developments taking place; (2) 

introduce U.S. companies to appropriate 

government officials in India to learn 

about various regulatory procedure and 

policies; and (3) introduce companies to 

potential end-users, representatives and 

partners. 

Mission Scenario 

The first stop on the mission itinerary 

is New Delhi, the capital. In meetings 

with representatives of the Ministry of 

Health, Drug Controller General Office, 

and Department of Pharmaceuticals, the 

U.S. mission members will learn about 

policies, regulations and opportunities 

in the country’s healthcare industry, 

such as expansion plans of the Fortis 

and Max hospital groups. 

Chennai and Mumbai are the second 

and third stops of the mission, located 

in southern and western India 

respectively. Several corporate hospital 

chains have their headquarters in these 

cities. These include the Apollo Group 

in Chennai, and Wockhard and the Tata 

Institute of Fundamental Research in 

Mumbai. 

The three cities on the mission 

itinerary are the regional hubs for the 

Indian medical/healthcare industry. 

End-users often prefer to be serviced by 

regional distributors/agents based in 

these cities, rather than country-wide 

distributors. In all three cities the 

delegates will attend U.S. Embassy or 

Consulate industry briefings and take 

part in networking events and business 

matchmaking appointments. 

Participation in the mission will 

include the following: 

• Pre-travel briefings/webinars on 

subjects including business practices in 

India and specifics on the medical/ 

healthcare industry; 

• Embassy/Consulate briefings on the 

business climate, political scenario, and 

medical/healthcare industry in New 

Delhi, Chennai and Mumbai; 

• Pre-scheduled meetings with 

potential partners, distributors, endusers, or local industry contacts in New 

Delhi, Chennai and Mumbai; 

• Meetings with Indian Government 

officials; 

• Tour of public and private hospitals 

and interaction with senior hospital 

staff; 

• Networking receptions in three 

cities of the trade mission; 

• Built-up 9-sq meter exhibitor 

booth* in the U.S. Pavilion at Medical 

Fair India, Mumbai. 

(Option two only) *Contact us for 

price of booth. 

Proposed Mission Timetable 

Mission participants will be 

encouraged to arrive Saturday, March 6, 

2010 to allow time to adjust to their new 

surroundings before the mission 

program begins on Monday, March 8. 

Monday, March 8 ............... New Delhi 

Embassy briefing by U.S. Departments of Commerce and State. 

Meetings with Government of India ministries. 

One-on-one business appointments. 

Evening: Networking reception. 

Tuesday, March 9 .............. New Delhi/Chennai 

Industry briefing. 

One-on-one business appointments. 

Hospital or other site visit. 

Check-out of the hotel. 

Evening flight to Chennai. 

Wednesday, March 10 ....... Chennai 

Breakfast briefing by the U.S. Commercial Service at hotel. 

Hospital visit and meeting with senior management, including the procurement executives. 

One-on-one business appointments. 

Evening: Networking reception. 

Thursday, March 11 .......... Chennai/Mumbai 

One-on-one business appointments. 

Check-out of the hotel. 

Afternoon flight to Mumbai. 

Friday, March 12 ............... Mumbai 

Breakfast briefing by the U.S. Commercial Service at hotel. 

One-on-one business appointments or exhibition at Medical Fair India. 

Evening: Networking reception. 

Saturday, March 13 ........... Mumbai 

Hospital chain visit and meeting with senior management. 

Medical Fair India 2010. 

Evening: Check-out of the hotel or remain in Mumbai for Medical Fair India. 

Depart for Mumbai International airport for onward travel. 

Participation Requirements 

All parties interested in participating 

in the Medical Trade Mission to India 

must complete and submit an 

application for consideration by the 

Department of Commerce. All 

applicants will be evaluated on their 

ability to meet certain conditions and 

best satisfy the selection criteria as 

outlined below. The mission is open on 

a first come first served basis to 15 

qualified U.S. companies. Additional 

applications will be considered as time 

and space permit. 

Fees and Expenses 

After a company has been selected to 

participate on the mission, a payment to 

mstockstill on DSKH9S0YB1PROD with NOTICES

Federal Register / Vol. 74, No. 156 / Friday, August 14, 2009 / Notices 41127 

*An SME is defined as a firm with 500 or fewer 

employees or that otherwise qualifies as a small 

business under SBA regulations (see http://

www.sba.gov/services/contractingopportunities/size

standardstopics/index.html). Parent companies, 

affiliates, and subsidiaries will be considered when 

determining business size. The dual pricing 

schedule reflects the Commercial Service’s user fee 

schedule that became effective May 1, 2008 (for 

additional information see http://www.export.gov/

newsletter/march2008/initiatives.html). 

**Minimum booth space is 9-sq meters. 

Companies can take larger space for which cost will 

be calculated accordingly. 

the Department of Commerce in the 

form of a participation fee is required. 

The participation fees reflect two 

options: 

Option 1: March 8–13, 2010. 

Participation in the Trade Mission in all 

three cities: New Delhi, Chennai, and 

Mumbai. The participation fee will be 

$4,600 for large firms and $3,900 for a 

small or medium-sized enterprise 

(SME),* this includes one principal 

representative. The fee for each 

additional firm representative (large 

firm or SME) is $500. 

Option 2: March 8–11, 2010 

participate in the Trade Mission in two 

cities: New Delhi and Chennai and 

March 12–14, exhibit at the Medical 

Fair India 2010 in Mumbai. The 

participation fee for New Delhi-Chennai 

and exhibiting in the Fair in Mumbai 

$6,800 ($3,600 Trade Mission fee + 

$3,200 for 9-sq meter booth space**) for 

large firms and $6,100 ($2,900 Trade 

Mission fee + $3,200 for 9-sq meter 

booth space) for an SME,* which 

includes one principal representative. 

The fee for each additional firm 

representative (large firm or SME) is 

$250. 

Expenses for lodging, some meals, 

incidentals, and travel (except for 

transportation to and from meetings) 

will be the responsibility of each 

mission participant. 

Conditions for Participation 

• An applicant must submit a 

completed and signed mission 

application and supplemental 

application materials, including 

adequate information on the company’s 

products and/or services, primary 

market objectives, and goals for 

participation. 

• Each applicant must also certify 

that the products and services it seeks 

to export through the mission are either 

produced in the United States, or, if not, 

marketed under the name of a U.S. firm 

and have at least fifty-one percent U.S. 

content. 

Selection Criteria for Participation 

Selection will be based on the 

following criteria: 

• Suitability of a company’s products 

or services to the mission’s goals. 

• Applicant’s potential for business 

in India, including likelihood of exports 

resulting from the trade mission. 

• Consistency of the applicant’s goals 

and objectives with the stated scope of 

the trade mission. 

Any partisan political activities 

(including political contributions) of an 

applicant are entirely irrelevant to the 

selection process. 

Timeframe for Recruitment and 

Applications 

Mission recruitment will be 

conducted in an open and public 

manner, including posting in the 

Federal Register, the Commerce 

Department trade mission calendar 

(http://www.ita.doc.gov/doctm/tmcal.

html), and other Internet Web sites; 

press releases to general and trade 

media; direct mail; notices by industry 

trade associations and other multiplier 

groups; and publicity at industry 

meetings, symposia, conferences, and 

trade shows. Recruitment for the 

mission will begin immediately and 

conclude no later than January 8, 2010. 

Contacts 

U.S. Commercial Service; Healthcare 

Team 

Ms. Jetta DeNend, International Trade 

Specialist, U.S. Commercial 

Service, 33 Whitehall St. 22nd 

Floor, New York, NY 10004. Ph: 

212–809–2644/Fax: 212–809–268. 

E-mail: Jetta.DeNend@mail.doc.gov. 

U.S. Commercial Service in India 

Mr. Srimoti Mukherji, U.S. 

Commercial Service, New Delhi. 

Ph: 91–11–23472000, ext 2226. Fax: 

91–11–23315172. 

Srimoti.Mukherji@mail.doc.gov. 

Lisa Huot, 

Global Trade Programs, Commercial Service 

Trade Missions Program. 

[FR Doc. E9–19565 Filed 8–13–09; 8:45 am] 

BILLING CODE 3510–DS–P 

DEPARTMENT OF COMMERCE 

National Oceanic and Atmospheric 

Administration 

Notice of Modifications for the GOES 

Data Collection Platform Radio Set 

(DCPRS) Certification Standards at 300 

bps and 1200 bps 

SUMMARY: NOAA is making a change to 

the certification standards for the 

transmitters that participate in the 

GOES Data Collection System (DCS). 

The primary purpose of this change is 

to enhance the flexibility of the system, 

to provide better messaging capabilities, 

additional system capacity, improve 

timing and frequency stability, and 

conform to the regulations for out-ofband emissions specified by the 

National Telecommunication and 

Information Administration (NTIA). The 

GOES DCS will operate under new 

certification procedures that will allow 

new data collection platforms to use a 

frequency channel with half the current 

bandwidth (.75 Hz), though existing 

platforms will continue to use frequency 

channels with 1.5 Hz bandwidth until 

suitable replacements are ascertained. 

The owners of the existing platforms are 

invited to upgrade their units as soon as 

possible. New data collection platforms 

will be assigned a narrow band channel 

in the restructured GOES DCS. These 

new certification standards may be 

reviewed on the NOAA Web site: http:// 

noaasis.noaa.gov/DCS/docs/DCPR_

CS2final.doc. 

DATES: Start of service [October 1, 2009]. 

FOR FURTHER INFORMATION CONTACT: 

Comments may be provided to the 

NOAA GOES DCS Program Manager, at 

Kay.Metcalf@noaa.gov or you can 

contact her at 301–817–4558. 

SUPPLEMENTARY INFORMATION: Since the 

advent of the Geostationary Operational 

Environmental Satellites (GOES) and 

the on-board transponder, 

environmental data from remote 

platforms has been collected and 

relayed in real time to federal and 

international environmental managers 

and scientists. Known as the GOES Data 

Collection System (DCS), this satellite 

transmission technology consists of over 

20,000 Data Collection Platforms 

(DCPs), dedicated satellite receive and 

transmit capability, and ground/satellite 

processing and distribution equipment. 

Data collected from DCPs measures or 

monitors such varied parameters as 

rainfall, river stage levels, soil 

conditions, seismic or tsunami 

conditions, aircraft flight environment 

and fire conditions. These data are also 

used to verify and serve as ‘‘ground 

truth’’ for other types of remotely sensed 

data such as NEXRAD and satellitederived precipitation estimates. DCS 

data provides fast, reliable information 

for flood, fire, tsunami and other 

disaster forecasts and warnings 

amounting to incalculable savings in 

lives and property damage. 

This system provides critical support 

to the U.S. Corp of Engineers, U.S. 

Geological Survey, the Bureau of Land 

Management, the National Weather 

Service and other federal and state 

agencies to monitor and forecast the 

flood stages in the upper Mississippi 

mstockstill on DSKH9S0YB1PROD with NOTICES